Liver Metastases of Colorectal Cancer: a Survival Analysis

Wei Ye
2011-01-01
Abstract:Objective To investigate survival in patients with liver metastases of colorectal cancer and identify risk factors associated with survival. Methods Clinical, pathologic, treatment and complete follow-up data of the consecutive cases of colorectal liver metastasis admitted between 2000 and 2010 in Zhongshan Hospital of Fudan University were analyzed retrospectively. The prognostic value of different factors was studied through univariate and multivariate analyses. Results The median survival was 22.0 months and 5-year survival rate was 16%. Survival of synchronous liver metastases (21.2 months and 16%) was lower than that of metachronous liver metastases (30.1 months and 23%, P0.01). Survival after resection of liver metastases was 49.8 months and 37%, which was higher than that after chemotherapy (22.2 months and 0), that after intervention(19.0 months and 11%), that after chemotherapy combined with intervention(22.8 months and 10%)and that after local regional treatment (28.5 months and 0). Five factors were found to be significant and independent predictors of poor survival by multivariate analysis: simultaneous liver metastases (P=0.005), poorly differentiated primary (P=0.005), number of liver metastases ≥ 4 (P=0.008), largest liver metastases ≥ 5 cm (P=0.007), and no surgical treatment of liver metastases (P0.001). Conclusion Survival of synchronous liver metastases is lower than that of metachronous liver metastases. Resection of liver metastases provides good long-term survival benifit for patients with resectable and initially irresectable liver metastases. Expansion of the indications for liver resection is acceptable. Long-term survival outcome can be predicted from a risk factor scoring system.
What problem does this paper attempt to address?